Development and formulation
We offer the technical capability, skill and experience to perform rigorous evaluations of your drug candidates.
Working as your partner, we ensure your candidates’ compatibility with the InstaPill® platform and help to develop efficient, robust processes and analytical approaches that ensure you have the data you need to successfully commercialize the right products.
Our specialists can help you formulate a lyophilized ODT with effective task masking, which is either equivalent or superior to conventional ODT performance (with dose up to 200 mg for insoluble APIs and 20 mg for soluble APIs).
Our facilities are equipped with the latest models of lyophilizers at different working ranges from lab and pilot scale to commercial scale.
Our team has expertise in optimizing lyophilization cycles using advanced technologies, helping to reduce the cost of manufacturing and providing lyophilized RDTs at a more affordable price.
This means you can successfully commercialize lyophilized RDTs with advanced taste-masking and flavor-enhancing techniques.
From our state-of-the-art manufacturing facility in India, InstaPill® offers highly automated operations to improve speed, accuracy, and quality to ensure dosage uniformity and precision.
Our capacity allows us to scale-up for our partners and produce approximately 270 million rapid dissolve tablets annually, ensuring consistent supply.